Actively Recruiting
The Significance of Remnant Cholesterol and Carotid Intima Media Thickness in Patients With MAFLD
Led by Assiut University · Updated on 2024-06-07
60
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
1. To detect the significance of remenant cholesterol in detection severity of MAFLD 2. To detect the significance of carotid intima-media thickness in MAFLD
CONDITIONS
Official Title
The Significance of Remnant Cholesterol and Carotid Intima Media Thickness in Patients With MAFLD
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients aged 18 years or older
- Diagnosed with metabolic dysfunction-associated fatty liver disease (MAFLD)
- Presented to a fibroscan clinic
You will not qualify if you...
- Known previous cardiac disease such as cardiovascular disease, heart failure, or arrhythmia
- Known liver cirrhosis
- Septic patients
- Patients with malignancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Assiut University
Asyut, Egypt, 71515
Actively Recruiting
Research Team
A
Ahmed Kh Nazier
CONTACT
M
Marwa Mo Mahmoud
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here